Cartesian Therapeutics Announces Retreatment Data for Descartes-08
Cartesian Therapeutics presented retreatment data for Descartes-08, showing deep and durable responses in myasthenia gravis patients.
Cartesian Therapeutics presented retreatment data for Descartes-08, showing deep and durable responses in myasthenia gravis patients.